Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: J Immunother. 2018 Oct;41(8):361–368. doi: 10.1097/CJI.0000000000000242

Fig. 2.

Fig. 2

Fig. 2

CSC-DC vaccination combined with immune checkpoints blockade significantly enhanced the elimination of ALDHhigh CSCs. A, FACS plots showing the percentage of ALDHhigh CSCs in the residual tumors of mice subjected to treatments as indicated. Single-cell residual tumor suspensions were prepared from tumors on day 30 and stained for ALDEFLUOR. B, The percentage and statistical analyses of ALDHhigh CSCs in residual tumors of mice treated as indicated. Each column represents the mean±SE of three independent experiments performed.